Tranexamic acid is a synthetic derivative of the amino acid lysine, developed in the 1960s as a medicine to reduce bleeding. Its use in skincare came about entirely by accident.
The original discovery
Tranexamic acid works medically by blocking the conversion of plasminogen to plasmin, an enzyme that dissolves blood clots. Preventing that conversion helps clots hold, which is why it is prescribed for heavy menstrual bleeding, in surgery, and in trauma medicine.
In 1979 a Japanese physician noticed that patients taking it orally for a bleeding disorder showed unexpected lightening of their melasma. That observation started four decades of research into pigmentation.
How it acts on pigment
The mechanism connects back to the same plasminogen pathway.
UV exposure increases plasmin activity in keratinocytes. Plasmin in turn releases arachidonic acid and prostaglandins, which stimulate melanocytes to produce pigment. Tranexamic acid interrupts that signal before melanocyte stimulation occurs.
This is why it is described as working upstream. Vitamin C, kojic acid and arbutin inhibit tyrosinase, the enzyme that builds melanin. Niacinamide interferes with pigment transfer after it is made. Tranexamic acid reduces the instruction to produce it in the first place.
That makes it complementary to those ingredients rather than a substitute, which is why formulations frequently combine several.
It also appears to have effects on the vascular component of melasma, reducing the increased capillary activity often present in affected skin.
The evidence, by route
Worth separating clearly, because the three routes have very different evidence bases.
Oral tranexamic acid for melasma has the strongest evidence, with multiple trials reporting significant improvement. It is prescription-only and carries genuine risks, principally thrombosis, which is why it is used cautiously and not for everyone.
Injected into the skin, there is reasonable supporting evidence.
Topical is the weakest of the three, though studies do report benefit, and it avoids the systemic risks entirely. Formulations typically use 2 to 5 percent.
This distinction matters. The impressive melasma results that circulate in discussion of tranexamic acid usually come from the oral route, and they do not transfer directly to a cream.
Why it appears in gentle formulations
Unlike hydroquinone or high-strength acids, topical tranexamic acid is well tolerated and does not cause the irritation that can worsen post-inflammatory pigmentation. That makes it useful for deeper skin tones, where aggressive treatment carries a real risk of making pigmentation worse.
Who should ask a doctor
Systemic absorption from topical cosmetic use is minimal, and topical use is not equivalent to taking the medicine.
That said, tranexamic acid is a real medicine with real contraindications. Anyone with a history of blood clots, thrombosis, or who takes anticoagulant medication should raise it with their doctor rather than assume topical use is irrelevant to them. The same applies during pregnancy.
